Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Verdoorn Todd A.
Chief Scientific Officer at DiaMedica Therapeutics. Filing since 11 Dec 2018.
CIK 0001759883
Company
Date
Role
Action
Shares
Amount
Of holding
DMAC
DiaMedica Therapeutics Inc.
11 Dec 2018
Chief Scientific Officer
Bought
1,000
$4.00K
100%
1 decision on file.